Menlo Park, CA – According to filings with the U.S. Securities and Exchange Commission, Credence MedSystems is raising $20,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Jeff Shanley played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Credence MedSystems

Credence MedSystems is setting a new standard in drug delivery, helping our pharmaceutical customers differentiate their products through innovative delivery systems while preserving their trusted processes. Credence MedSystems has changed the paradigm for drug manufacturers commercializing an injectable drug in a differentiated delivery system. Credence MedSystems is an industry-recognized and award-winning innovator in injectable drug delivery devices for pharmaceutical and biotechnology manufacturers. The Company’s broad family of drug delivery devices, which are protected by a robust intellectual property portfolio, addresses the evolving needs of the biopharmaceutical industry.

To learn more about Credence MedSystems, visit http://www.credencemed.com/

Contact:
Jeff Shanley, Chief Executive Officer
844-263-3797

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved